Protection of salvianolate against atherosclerosis via regulating the inflammation in rats

Abstract

Inflammation plays an essential role in the pathophysiology of atherosclerosis. Our study was aimed to investigate whether salvianolate, a novel water-soluble phenolic compound of Danshen, alleviates atherosclerosis via regulating the inflammation in rats. High fat diet feeding plus vitamin D3 injection was used to induce atherosclerosis in rats. Salvianolate (60, 120 or 240 mg/kg) or placebo was given to atherosclerotic rats. The plasma lipids, interleukin 6 (IL-6) and C reactive protein (CRP) were measured by ELISA. CD4+CD25+Foxp3+ cells were determined by flow cytometry. Histological changes were examined by hematoxylin and eosin staining. The results showed that the levels of plasma IL-6 and CRP were elevated in the rats fed on high fat diet, and the histological analysis demonstrated the successful establishment of atherosclerosis models. Treatment with salvianolate alleviated the atherosclerotic process and decreased the levels of plasma IL-6 and CRP. Also the number of CD4+CD25+Foxp3+ cells was increased in salvianolate-treated rats. It was concluded that salvianolate could treat atherosclerosis via modulating the inflammation at cytokine and cell levels.

Keywords

atherosclerosis / salvianolate / interleukin 6 / Tregulatory cells / C reactive protein

References

[1] JiangY, WeiN, LuT, et al.. Intranasal brain-derived neurotrophic factor protects brain from ischemic insult via modulating local inflammation in rats. Neuroscience, 2011, 17: 398-405

[2] ErenE, YilmazN, AydinO. Functionally defective high-density lipoprotein and paraoxonase: A couple for endothelial dysfunction in atherosclerosis. Cholesterol, 2013, 2013: 792090

[3] BrottTG, HalperinJL, AbbaraS, et al.. 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/S CAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography. Catheter Cardiovasc Interv, 2013, 81(1): E76-E123

[4] TabasI, GlassCK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science, 2013, 339(6116): 166-172

[5] FujimotoM, NakanoM, TerabeF, et al.. The influence of excessive IL-6 production in vivo on the development and function of Foxp3+ regulatory T cells. J Immunol, 2011, 186(1): 32-40

[6] LiN. CD4+ T cells in atherosclerosis: regulation by platelets. Thromb Haemost, 2013, 109(6): 980-990

[7] Di NapoliM, ElkindMS, GodoyDA, et al.. Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Rev Cardiovasc Ther, 2011, 9(12): 1565-1584

[8] StumpfC, FanQ, HintermannC, et al.. Anti-inflammatory effects of danshen on human vascular endothelial cells in culture. Am J Chin Med, 2013, 41(5): 1065-1077

[9] ChoYH, KuCR, HongZY, et al.. Therapeutic effects of water soluble danshen extracts on atherosclerosis. Evid Based Complement Alternat Med, 2013, 2013: 623639

[10] HanB, ZhangX, ZhangQ, et al.. Protective effects of salvianolate on microvascular flow in a porcine model of myocardial ischaemia and reperfusion. Arch Cardiovasc Dis, 2011, 104(5): 313-324

[11] YangDH, YeZY, JinB, et al.. Salvianolate inhibits cytokine gene expression in small intestine of cirrhotic rats. World J Gastroenterol, 2011, 17(14): 1903-1909

[12] LiCS, QuZQ, WangSS, et al.. Effects of suxiao jiuxin pill (see test) on oxidative stress and inflammatory response in rats with experimental atherosclerosis. J Tradit Chin Med, 2011, 31(2): 107-111

[13] TardyC, GoffinetM, BoubekeurN, et al.. CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice. Atherosclerosis, 2014, 232(1): 110-118

[14] ChengTJ, ChuuJJ, ChangCY, et al.. Atherosclerosis induced by arsenic in drinking water in rats through altering lipid metabolism. Toxicol Appl Pharmacol, 2011, 256(2): 146-153

[15] WheltonSP, RoyP, AstorBC, et al.. Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study. Am J Epidemiol, 2013, 178(7): 1076-1084

[16] LiuGT, ZhangTM, WangBE, et al.. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochem Pharmacol, 1992, 43(2): 147-152

[17] KannelWB. Overview of atherosclerosis. Clin Ther, 1998, 20(SupplB): B2-B17

[18] KimJS, NarulaAS, JobinC. Salvia miltiorrhiza water-soluble extract, but not its constituent salvianolic acid B, abrogates LPS-induced NF-kappaB signalling in intestinal epithelial cells. Clin Exp Immunol, 2005, 141(2): 288-297

[19] GuoJ, SunK, WangCS, et al.. Protective effects of dihydroxylphenyl lactic acid and salvianolic acid B on LPS-induced mesenteric microcirculatory disturbance in rats. Shock, 2008, 29(2): 205-211

[20] PoledneR, LorenzovaA, StavekP, et al.. Proinflammatory status, genetics and atherosclerosis. Physiol Res, 2009, 58(Suppl2): S111-S118

[21] SakaguchiS. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol, 2004, 22: 531-562

[22] GershonRK, KondoK. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology, 1970, 18(5): 723-737

[23] SakaguchiS, SakaguchiN, AsanoM, et al.. Pillars article: immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol, 2011, 186(7): 3808-3821

[24] SakaguchiS, WingK, MiyaraM. Regulatory T cells — a brief history and perspective. Eur J Immunol, 2007, 37(Suppl1): S116-123

[25] Baecher-AllanC, BrownJA, FreemanGJ, et al.. CD4+CD25 high regulatory cells in human peripheral blood. J Immunol, 2001, 167(3): 1245-1253

[26] DieckmannD, PlottnerH, BerchtoldS, et al.. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med, 2001, 193(11): 1303-1310

[27] LevingsMK, SangregorioR, RoncaroloMG. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med, 2001, 193(11): 1295-1302

[28] MaloyKJ, PowrieF. Regulatory T cells in the control of immune pathology. Nat Immunol, 2001, 2(9): 816-822

[29] NgWF, DugganPJ, PonchelF, et al.. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood, 2001, 98(9): 2736-2744

[30] HoriS, NomuraT, SakaguchiS. Control of regulatory T cell development by the transcription factor Foxp3. Science, 2003, 299(5609): 1057-1061

[31] HanssonGK. Atherosclerosis—an immune disease: The Anitschkov Lecture 2007. Atherosclerosis, 2009, 202(1): 2-10

[32] HeS, LiM, MaX, et al.. CD4+CD25+Foxp3+ regulatory T cells protect the proinflammatory activation of human umbilical vein endothelial cells. Arterioscler Thromb Vasc Biol, 2010, 30(12): 2621-2630